_id
691314c6ccc777a4e85d8020
Ticker
MEDXF
Name
Medexus Pharmaceuticals Inc
Exchange
OTCQX
Address
10 King Street East, Toronto, ON, Canada, M5C 1C3
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.medexus.com
Description
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection to treat allogeneic hematopoietic stem cell transplantation in adult and pediatric patients, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS); and Gleolan, an optical imaging agent for patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was founded in 2000 and is based in Toronto, Canada.
Last Close
2.15
Volume
2200
Current Price
2.05
Change
0.124
Last Updated
2026-01-05T10:20:11.811Z
Image
data:image/webp;base64,UklGRroAAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSEUAAAABYBTbdhN1kZAAPhBSVljqRU7qFZC6YiJiAqYl6nkdidtzaRe1YXNE7Tn+v4XYHmL74guxPS62o/0ZH7VlI27PJVXUchAAVlA4IE4AAAAwBACdASpAAEAAPtFgqE6oJaQiKggBABoJZwDRgCKZXAwJfjuMfyTCs4gA8Y/nDc3Xv8TeVbXMta6//YB9g4clOEoyrkIl/BXPF90oAAA=
Ipo Date
-
Market Cap
73589664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
24741000
Cost Of Revenue
10955000
Gross Profit
13786000
Operating Expenses
23088000
Operating Income
1653000
Interest Expense
1407000
Pretax Income
-327000
Net Income
-315000
Eps
-0.00971620657087001
Dividends Per Share
0
Shares Outstanding
32420060
Income Tax Expense
-
EBITDA
-
Operating Margin
6.681217412392384
Total Other Income Expense Net
-573000
Cash
9381000
Short Term Investments
-
Receivables
12024000
Inventories
34234000
Total Current Assets
62432000
Property Plant Equipment
507000
Total Assets
149441000
Payables
37687000
Short Term Debt
-
Long Term Debt
118000
Total Liabilities
97023000
Equity
52418000
Bs_currency_symbol
USD
Depreciation
2428000
Change In Working Capital
-290000
Cash From Operations
3337000
Capital Expenditures
7000
Cash From Investing
-
Cash From Financing
-1599000
Net Change In Cash
83000
Cf_currency_symbol
USD
PE
223.9
PB
1.2679065015834254
ROE
-0.600938608874814
ROA
-0.21078552739877277
FCF
3330000
Fcf Percent
0.1345943979628956
Piotroski FScore
2
Health Score
37
Deep Value Investing Score
5.5
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
4
Quality Investing Score
4
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
24741000
Quarters > 0 > income Statement > cost Of Revenue
10955000
Quarters > 0 > income Statement > gross Profit
13786000
Quarters > 0 > income Statement > operating Expenses
23088000
Quarters > 0 > income Statement > operating Income
1653000
Quarters > 0 > income Statement > interest Expense
1407000
Quarters > 0 > income Statement > pretax Income
-327000
Quarters > 0 > income Statement > net Income
-315000
Quarters > 0 > income Statement > eps
-0.00971620657087001
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
32420060
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
6.681217412392384
Quarters > 0 > income Statement > total Other Income Expense Net
-573000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
9381000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
12024000
Quarters > 0 > balance Sheet > inventories
34234000
Quarters > 0 > balance Sheet > total Current Assets
62432000
Quarters > 0 > balance Sheet > property Plant Equipment
507000
Quarters > 0 > balance Sheet > total Assets
149441000
Quarters > 0 > balance Sheet > payables
37687000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
118000
Quarters > 0 > balance Sheet > total Liabilities
97023000
Quarters > 0 > balance Sheet > equity
52418000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-315000
Quarters > 0 > cash Flow > depreciation
2428000
Quarters > 0 > cash Flow > change In Working Capital
-290000
Quarters > 0 > cash Flow > cash From Operations
3337000
Quarters > 0 > cash Flow > capital Expenditures
7000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-1599000
Quarters > 0 > cash Flow > net Change In Cash
83000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.00971620657087001
Quarters > 0 > ratios > PB
1.2679065015834254
Quarters > 0 > ratios > ROE
-0.600938608874814
Quarters > 0 > ratios > ROA
-0.21078552739877277
Quarters > 0 > ratios > FCF
3330000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.1345943979628956
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
24615000
Quarters > 1 > income Statement > cost Of Revenue
10841000
Quarters > 1 > income Statement > gross Profit
13774000
Quarters > 1 > income Statement > operating Expenses
23765000
Quarters > 1 > income Statement > operating Income
850000
Quarters > 1 > income Statement > interest Expense
1406000
Quarters > 1 > income Statement > pretax Income
615000
Quarters > 1 > income Statement > net Income
516000
Quarters > 1 > income Statement > eps
0.015995856949051306
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
32258353
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
3.4531789559211865
Quarters > 1 > income Statement > total Other Income Expense Net
1171000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9332000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
12215000
Quarters > 1 > balance Sheet > inventories
35398000
Quarters > 1 > balance Sheet > total Current Assets
64218000
Quarters > 1 > balance Sheet > property Plant Equipment
573000
Quarters > 1 > balance Sheet > total Assets
153793000
Quarters > 1 > balance Sheet > payables
39691000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
159000
Quarters > 1 > balance Sheet > total Liabilities
100832000
Quarters > 1 > balance Sheet > equity
52961000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
709830
Quarters > 1 > cash Flow > depreciation
2426000
Quarters > 1 > cash Flow > change In Working Capital
580000
Quarters > 1 > cash Flow > cash From Operations
3919000
Quarters > 1 > cash Flow > capital Expenditures
125000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-16291000
Quarters > 1 > cash Flow > net Change In Cash
-14713000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.015995856949051306
Quarters > 1 > ratios > PB
1.248647564245388
Quarters > 1 > ratios > ROE
0.9743018447536866
Quarters > 1 > ratios > ROA
0.33551592075061937
Quarters > 1 > ratios > FCF
3794000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.15413365833841153
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
24754000
Quarters > 2 > income Statement > cost Of Revenue
12322000
Quarters > 2 > income Statement > gross Profit
12432000
Quarters > 2 > income Statement > operating Expenses
25044000
Quarters > 2 > income Statement > operating Income
-290000
Quarters > 2 > income Statement > interest Expense
2005000
Quarters > 2 > income Statement > pretax Income
-759000
Quarters > 2 > income Statement > net Income
-553000
Quarters > 2 > income Statement > eps
-0.017142846691522037
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
32258353
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-1.1715278338854327
Quarters > 2 > income Statement > total Other Income Expense Net
1536000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
23973000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
13170000
Quarters > 2 > balance Sheet > inventories
35290000
Quarters > 2 > balance Sheet > total Current Assets
80572000
Quarters > 2 > balance Sheet > property Plant Equipment
689000
Quarters > 2 > balance Sheet > total Assets
171838000
Quarters > 2 > balance Sheet > payables
5730000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
198000
Quarters > 2 > balance Sheet > total Liabilities
119695000
Quarters > 2 > balance Sheet > equity
52143000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-760380
Quarters > 2 > cash Flow > depreciation
2436000
Quarters > 2 > cash Flow > change In Working Capital
619000
Quarters > 2 > cash Flow > cash From Operations
2276000
Quarters > 2 > cash Flow > capital Expenditures
53000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
15166000
Quarters > 2 > cash Flow > net Change In Cash
15379000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.017142846691522037
Quarters > 2 > ratios > PB
1.2682358830523752
Quarters > 2 > ratios > ROE
-1.0605450396026312
Quarters > 2 > ratios > ROA
-0.32181473248059217
Quarters > 2 > ratios > FCF
2223000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.08980366809404541
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
29992000
Quarters > 3 > income Statement > cost Of Revenue
14801000
Quarters > 3 > income Statement > gross Profit
15191000
Quarters > 3 > income Statement > operating Expenses
26211000
Quarters > 3 > income Statement > operating Income
3781000
Quarters > 3 > income Statement > interest Expense
1996000
Quarters > 3 > income Statement > pretax Income
880000
Quarters > 3 > income Statement > net Income
733000
Quarters > 3 > income Statement > eps
0.029673406713144748
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
24702253
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
12.606695118698319
Quarters > 3 > income Statement > total Other Income Expense Net
-905000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8441000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
14138000
Quarters > 3 > balance Sheet > inventories
34004000
Quarters > 3 > balance Sheet > total Current Assets
66718000
Quarters > 3 > balance Sheet > property Plant Equipment
712000
Quarters > 3 > balance Sheet > total Assets
145978000
Quarters > 3 > balance Sheet > payables
39751000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
22165000
Quarters > 3 > balance Sheet > total Liabilities
112877000
Quarters > 3 > balance Sheet > equity
33101000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
1047330
Quarters > 3 > cash Flow > depreciation
1756000
Quarters > 3 > cash Flow > change In Working Capital
1294000
Quarters > 3 > cash Flow > cash From Operations
6710000
Quarters > 3 > cash Flow > capital Expenditures
104000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-4461000
Quarters > 3 > cash Flow > net Change In Cash
1770000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.029673406713144748
Quarters > 3 > ratios > PB
1.5298516253285397
Quarters > 3 > ratios > ROE
2.2144346092263074
Quarters > 3 > ratios > ROA
0.5021304580142213
Quarters > 3 > ratios > FCF
6606000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.22025873566284343
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
108332000
Annuals > 0 > income Statement > cost Of Revenue
51748000
Annuals > 0 > income Statement > gross Profit
56584000
Annuals > 0 > income Statement > operating Expenses
96411000
Annuals > 0 > income Statement > operating Income
11921000
Annuals > 0 > income Statement > interest Expense
8195000
Annuals > 0 > income Statement > pretax Income
1440000
Annuals > 0 > income Statement > net Income
2247000
Annuals > 0 > income Statement > eps
0.06965713283615232
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
32258003
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
11.004135435513053
Annuals > 0 > income Statement > total Other Income Expense Net
-2286000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
23973000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
13170000
Annuals > 0 > balance Sheet > inventories
35290000
Annuals > 0 > balance Sheet > total Current Assets
80572000
Annuals > 0 > balance Sheet > property Plant Equipment
689000
Annuals > 0 > balance Sheet > total Assets
171838000
Annuals > 0 > balance Sheet > payables
5730000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
198000
Annuals > 0 > balance Sheet > total Liabilities
119695000
Annuals > 0 > balance Sheet > equity
52143000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2247000
Annuals > 0 > cash Flow > depreciation
7178000
Annuals > 0 > cash Flow > change In Working Capital
5843000
Annuals > 0 > cash Flow > cash From Operations
24034000
Annuals > 0 > cash Flow > capital Expenditures
2726000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
796000
Annuals > 0 > cash Flow > net Change In Cash
18829000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.06965713283615232
Annuals > 0 > ratios > PB
1.3795782116487352
Annuals > 0 > ratios > ROE
4.309303262182843
Annuals > 0 > ratios > ROA
1.3076269509654441
Annuals > 0 > ratios > FCF
21308000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.19669165158955804
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
113054000
Annuals > 1 > income Statement > cost Of Revenue
53540000
Annuals > 1 > income Statement > gross Profit
59514000
Annuals > 1 > income Statement > operating Expenses
100267000
Annuals > 1 > income Statement > operating Income
12787000
Annuals > 1 > income Statement > interest Expense
13364000
Annuals > 1 > income Statement > pretax Income
106000
Annuals > 1 > income Statement > net Income
-214000
Annuals > 1 > income Statement > eps
-0.008749617153141973
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
24458213
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
11.310524174288393
Annuals > 1 > income Statement > total Other Income Expense Net
683000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
5255000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
23869000
Annuals > 1 > balance Sheet > inventories
30772000
Annuals > 1 > balance Sheet > total Current Assets
72496000
Annuals > 1 > balance Sheet > property Plant Equipment
778000
Annuals > 1 > balance Sheet > total Assets
155733000
Annuals > 1 > balance Sheet > payables
7750000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
34153000
Annuals > 1 > balance Sheet > total Liabilities
125410000
Annuals > 1 > balance Sheet > equity
30323000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-292240
Annuals > 1 > cash Flow > depreciation
5806000
Annuals > 1 > cash Flow > change In Working Capital
2341000
Annuals > 1 > cash Flow > cash From Operations
18714000
Annuals > 1 > cash Flow > capital Expenditures
266000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-23048000
Annuals > 1 > cash Flow > net Change In Cash
-7812000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.008749617153141973
Annuals > 1 > ratios > PB
1.7986945549582825
Annuals > 1 > ratios > ROE
-0.7057349206872671
Annuals > 1 > ratios > ROA
-0.13741467768552587
Annuals > 1 > ratios > FCF
18448000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.16317865798644896
Annuals > 1 > health Score
32
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
108096000
Annuals > 2 > income Statement > cost Of Revenue
48058000
Annuals > 2 > income Statement > gross Profit
60038000
Annuals > 2 > income Statement > operating Expenses
99607000
Annuals > 2 > income Statement > operating Income
8489000
Annuals > 2 > income Statement > interest Expense
13606000
Annuals > 2 > income Statement > pretax Income
-5041000
Annuals > 2 > income Statement > net Income
1221000
Annuals > 2 > income Statement > eps
0.06062857682534471
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
20139018
Annuals > 2 > income Statement > income Tax Expense
-6262000
Annuals > 2 > income Statement > EBITDA
14646000
Annuals > 2 > income Statement > operating Margin
7.853204558910598
Annuals > 2 > income Statement > total Other Income Expense Net
76000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
13069000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
21971000
Annuals > 2 > balance Sheet > inventories
22848000
Annuals > 2 > balance Sheet > total Current Assets
72969000
Annuals > 2 > balance Sheet > property Plant Equipment
899000
Annuals > 2 > balance Sheet > total Assets
161329000
Annuals > 2 > balance Sheet > payables
33415000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
27377000
Annuals > 2 > balance Sheet > total Liabilities
138881000
Annuals > 2 > balance Sheet > equity
22448000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1609790
Annuals > 2 > cash Flow > depreciation
6081000
Annuals > 2 > cash Flow > change In Working Capital
-15262000
Annuals > 2 > cash Flow > cash From Operations
-1444000
Annuals > 2 > cash Flow > capital Expenditures
61000
Annuals > 2 > cash Flow > cash From Investing
-1721000
Annuals > 2 > cash Flow > cash From Financing
6405000
Annuals > 2 > cash Flow > net Change In Cash
3051000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.06062857682534471
Annuals > 2 > ratios > PB
2.000624115288667
Annuals > 2 > ratios > ROE
5.439237348538845
Annuals > 2 > ratios > ROA
0.7568385101252719
Annuals > 2 > ratios > FCF
-1505000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.01392280935464772
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
76701000
Annuals > 3 > income Statement > cost Of Revenue
38774000
Annuals > 3 > income Statement > gross Profit
37927000
Annuals > 3 > income Statement > operating Expenses
89077000
Annuals > 3 > income Statement > operating Income
-12376000
Annuals > 3 > income Statement > interest Expense
12223000
Annuals > 3 > income Statement > pretax Income
-3820000
Annuals > 3 > income Statement > net Income
-2879000
Annuals > 3 > income Statement > eps
-0.1442924203427153
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
19952538
Annuals > 3 > income Statement > income Tax Expense
-941000
Annuals > 3 > income Statement > EBITDA
14548000
Annuals > 3 > income Statement > operating Margin
-16.135382850288785
Annuals > 3 > income Statement > total Other Income Expense Net
20779000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10018000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
13391000
Annuals > 3 > balance Sheet > inventories
21351000
Annuals > 3 > balance Sheet > total Current Assets
49111000
Annuals > 3 > balance Sheet > property Plant Equipment
1221000
Annuals > 3 > balance Sheet > total Assets
139225000
Annuals > 3 > balance Sheet > payables
12046000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
39816000
Annuals > 3 > balance Sheet > total Liabilities
121433000
Annuals > 3 > balance Sheet > equity
17792000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3724040
Annuals > 3 > cash Flow > depreciation
6143000
Annuals > 3 > cash Flow > change In Working Capital
4730000
Annuals > 3 > cash Flow > cash From Operations
-1180000
Annuals > 3 > cash Flow > capital Expenditures
97000
Annuals > 3 > cash Flow > cash From Investing
-8196000
Annuals > 3 > cash Flow > cash From Financing
663000
Annuals > 3 > cash Flow > net Change In Cash
-8686000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.1442924203427153
Annuals > 3 > ratios > PB
2.5007958486960433
Annuals > 3 > ratios > ROE
-16.181429856115106
Annuals > 3 > ratios > ROA
-2.067875740707488
Annuals > 3 > ratios > FCF
-1277000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.016649065853117952
Annuals > 3 > health Score
16
Valuation > metrics > PE
223.9
Valuation > metrics > PB
1.2679065015834254
Valuation > final Score
50
Valuation > verdict
397.8% Overvalued
Profitability > metrics > ROE
-0.600938608874814
Profitability > metrics > ROA
-0.5045489492567914
Profitability > metrics > Net Margin
-0.012731902510003638
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.8509481475828913
Risk > metrics > Interest Coverage
1.1748400852878464
Risk > final Score
35
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6565924589380954
Liquidity > metrics > Quick Ratio
0.7482155650489559
Liquidity > final Score
79
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
80
Prev Valuations > 2
100
Prev Profitabilities > 0
8
Prev Profitabilities > 1
0
Prev Profitabilities > 2
11
Prev Risks > 0
32
Prev Risks > 1
17
Prev Risks > 2
14
Prev Liquidities > 0
77
Prev Liquidities > 1
100
Prev Liquidities > 2
83
Updated At
2026-01-20T22:11:37.093Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0083
Earnings History > 0 > eps Difference
0.0083
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
-0.0148
Earnings History > 1 > eps Difference
0.0048
Earnings History > 1 > surprise Percent
32.4324
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-12
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.02
Earnings History > 2 > eps Estimate
-0.0524
Earnings History > 2 > eps Difference
0.0724
Earnings History > 2 > surprise Percent
138.1679
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-25
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.02
Earnings History > 3 > eps Estimate
-0.0676
Earnings History > 3 > eps Difference
0.0476
Earnings History > 3 > surprise Percent
70.4142
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-05
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.03
Earnings History > 4 > eps Estimate
0.02
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
50
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-09-30
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.1048
Earnings History > 5 > eps Estimate
0.055
Earnings History > 5 > eps Difference
0.0498
Earnings History > 5 > surprise Percent
90.5455
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.08
Earnings History > 6 > eps Estimate
0.04
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
100
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-06-25
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.03
Earnings History > 7 > eps Estimate
-0.02
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
250
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-07
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.02
Earnings History > 8 > eps Estimate
0.03
Earnings History > 8 > eps Difference
-0.05
Earnings History > 8 > surprise Percent
-166.6667
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.05
Earnings History > 9 > eps Estimate
0.02
Earnings History > 9 > eps Difference
-0.07
Earnings History > 9 > surprise Percent
-350
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.03
Earnings History > 10 > eps Estimate
-0.01
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
400
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-21
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.34
Earnings History > 11 > eps Estimate
-0.05
Earnings History > 11 > eps Difference
0.39
Earnings History > 11 > surprise Percent
780
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-08
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.07
Earnings History > 12 > eps Estimate
-0.08
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
12.5
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.14
Earnings History > 13 > eps Estimate
-0.21
Earnings History > 13 > eps Difference
0.07
Earnings History > 13 > surprise Percent
33.3333
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.18
Earnings History > 14 > eps Estimate
-0.2
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
10
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-06-22
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.23
Earnings History > 15 > eps Estimate
-0.3
Earnings History > 15 > eps Difference
0.07
Earnings History > 15 > surprise Percent
23.3333
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-09
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.17
Earnings History > 16 > eps Estimate
-0.39
Earnings History > 16 > eps Difference
0.22
Earnings History > 16 > surprise Percent
56.4103
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.32
Earnings History > 17 > eps Estimate
-0.53
Earnings History > 17 > eps Difference
0.21
Earnings History > 17 > surprise Percent
39.6226
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.34
Earnings History > 18 > eps Estimate
-0.1675
Earnings History > 18 > eps Difference
-0.1725
Earnings History > 18 > surprise Percent
-102.9851
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-16
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.21
Earnings History > 19 > eps Estimate
-0.02
Earnings History > 19 > eps Difference
-0.19
Earnings History > 19 > surprise Percent
-950
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-01
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.93
Earnings History > 20 > eps Estimate
0.03
Earnings History > 20 > eps Difference
-0.96
Earnings History > 20 > surprise Percent
-3200
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-16
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.9275
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.9275
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-11
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.24
Earnings History > 22 > eps Estimate
0.02
Earnings History > 22 > eps Difference
-0.26
Earnings History > 22 > surprise Percent
-1300
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-22
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.11
Earnings History > 23 > eps Estimate
-0.06
Earnings History > 23 > eps Difference
-0.05
Earnings History > 23 > surprise Percent
-83.3333
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-18
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.15
Earnings History > 24 > eps Estimate
-0.06
Earnings History > 24 > eps Difference
-0.09
Earnings History > 24 > surprise Percent
-150
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-29
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0.03
Earnings History > 25 > eps Estimate
-0.04
Earnings History > 25 > eps Difference
0.07
Earnings History > 25 > surprise Percent
175
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-22
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.15
Earnings History > 26 > eps Estimate
-0.14
Earnings History > 26 > eps Difference
-0.01
Earnings History > 26 > surprise Percent
-7.1429
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.1116
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.1116
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-25
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.1
Earnings History > 28 > eps Estimate
-0.3
Earnings History > 28 > eps Difference
0.2
Earnings History > 28 > surprise Percent
66.6667
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-27
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.61
Earnings History > 29 > eps Estimate
-0.15
Earnings History > 29 > eps Difference
-0.46
Earnings History > 29 > surprise Percent
-306.6667
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-07-18
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.4802
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.4802
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0903
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.0903
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-02-27
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.15
Earnings History > 32 > eps Estimate
-0.15
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
0
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-27
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.06
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.06
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-24
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.15
Earnings History > 34 > eps Estimate
-0.15
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
0
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-06-28
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
BeforeMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.22
Earnings History > 35 > eps Estimate
-0.3
Earnings History > 35 > eps Difference
0.08
Earnings History > 35 > surprise Percent
26.6667
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-02-28
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.15
Earnings History > 36 > eps Estimate
-0.15
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
0
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-28
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.161
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.161
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-18
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.132
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
-0.132
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-06-27
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
AfterMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
0.2299
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.2299
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-12-31
Earnings History > 40 > report Date
2016-03-31
Earnings History > 40 > date
2015-12-31
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
0.2452
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.2452
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-09-30
Earnings History > 41 > report Date
2015-12-31
Earnings History > 41 > date
2015-09-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.1922
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
-0.1922
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-06-30
Earnings History > 42 > report Date
2015-09-30
Earnings History > 42 > date
2015-06-30
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.1477
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
-0.1477
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2015-03-31
Earnings History > 43 > report Date
2015-06-30
Earnings History > 43 > date
2015-03-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.2652
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
-0.2652
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-12-31
Earnings History > 44 > report Date
2015-03-31
Earnings History > 44 > date
2014-12-31
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.3088
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
-0.3088
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2014-09-30
Earnings History > 45 > report Date
2014-12-31
Earnings History > 45 > date
2014-09-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.2015
Earnings History > 45 > eps Estimate
0
Earnings History > 45 > eps Difference
-0.2015
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2014-06-30
Earnings History > 46 > report Date
2014-09-30
Earnings History > 46 > date
2014-06-30
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.221
Earnings History > 46 > eps Estimate
0
Earnings History > 46 > eps Difference
-0.221
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2014-03-31
Earnings History > 47 > report Date
2014-06-30
Earnings History > 47 > date
2014-03-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
USD
Earnings History > 47 > eps Actual
-0.1586
Earnings History > 47 > eps Estimate
0
Earnings History > 47 > eps Difference
-0.1586
Earnings History > 47 > surprise Percent
-
Earnings History > 48 > period
2013-12-31
Earnings History > 48 > report Date
2014-03-31
Earnings History > 48 > date
2013-12-31
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
USD
Earnings History > 48 > eps Actual
-0.2595
Earnings History > 48 > eps Estimate
0
Earnings History > 48 > eps Difference
-0.2595
Earnings History > 48 > surprise Percent
-
Earnings History > 49 > period
2013-09-30
Earnings History > 49 > report Date
2013-12-31
Earnings History > 49 > date
2013-09-30
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
USD
Earnings History > 49 > eps Actual
-1.1608
Earnings History > 49 > eps Estimate
0
Earnings History > 49 > eps Difference
-1.1608
Earnings History > 49 > surprise Percent
-
Earnings History > 50 > period
2013-06-30
Earnings History > 50 > report Date
2013-09-30
Earnings History > 50 > date
2013-06-30
Earnings History > 50 > before After Market
-
Earnings History > 50 > currency
USD
Earnings History > 50 > eps Actual
-0.1984
Earnings History > 50 > eps Estimate
0
Earnings History > 50 > eps Difference
-0.1984
Earnings History > 50 > surprise Percent
-
Earnings History > 51 > period
2013-03-31
Earnings History > 51 > report Date
2013-06-30
Earnings History > 51 > date
2013-03-31
Earnings History > 51 > before After Market
-
Earnings History > 51 > currency
USD
Earnings History > 51 > eps Actual
-0.6275
Earnings History > 51 > eps Estimate
0
Earnings History > 51 > eps Difference
-0.6275
Earnings History > 51 > surprise Percent
-
Earnings History > 52 > period
2012-12-31
Earnings History > 52 > report Date
2013-03-31
Earnings History > 52 > date
2012-12-31
Earnings History > 52 > before After Market
-
Earnings History > 52 > currency
USD
Earnings History > 52 > eps Actual
-1.4717
Earnings History > 52 > eps Estimate
0
Earnings History > 52 > eps Difference
-1.4717
Earnings History > 52 > surprise Percent
-
Earnings History > 53 > period
2012-09-30
Earnings History > 53 > report Date
2012-12-31
Earnings History > 53 > date
2012-09-30
Earnings History > 53 > before After Market
-
Earnings History > 53 > currency
USD
Earnings History > 53 > eps Actual
-0.4426
Earnings History > 53 > eps Estimate
0
Earnings History > 53 > eps Difference
-0.4426
Earnings History > 53 > surprise Percent
-
Earnings History > 54 > period
2012-06-30
Earnings History > 54 > report Date
2012-09-30
Earnings History > 54 > date
2012-06-30
Earnings History > 54 > before After Market
-
Earnings History > 54 > currency
USD
Earnings History > 54 > eps Actual
-2.8803
Earnings History > 54 > eps Estimate
0
Earnings History > 54 > eps Difference
-2.8803
Earnings History > 54 > surprise Percent
-
Earnings History > 55 > period
2011-12-31
Earnings History > 55 > report Date
2012-03-31
Earnings History > 55 > date
2011-12-31
Earnings History > 55 > before After Market
-
Earnings History > 55 > currency
USD
Earnings History > 55 > eps Actual
-2.4953
Earnings History > 55 > eps Estimate
0
Earnings History > 55 > eps Difference
-2.4953
Earnings History > 55 > surprise Percent
-
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection to treat allogeneic hematopoietic stem cell transplantation in adult and pediatric patients, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS); and Gleolan, an optical imaging agent for patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was founded in 2000 and is based in Toronto, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMedexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares - Investing News Network
11/20/2025
Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares Investing News Network
Read more →Medexus Pharmaceuticals (OTCQX: MEDXF) launches NCIB to buy back up to 2,983,650 shares Stock Titan
Read more →Showing 2 of 5
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Medexus Pharmaceuticals Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0083
Date
2025-09-30
EPS Actual
-0.01
EPS Estimate
-0.0148
EPS Difference
0.0048
Surprise Percent
32.4324%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.